Pharma Focus Asia

Repligen

LATEST NEWSRead more...

18

Jun 2024

Northwest Biotherapeutics Acquires Exclusive Rights to Dendritic Cell Technology Suite

Northwest Biotherapeutics a biotechnology company focused on DCVax personalized immune therapies for solid tumor cancers announced on June that it has acquired

18

Jun 2024

FDA Approves Phase II Study of Ruxoprubart for ANCA-Associated Vasculitis

NovelMed is pleased to announce that Ruxoprubart an experimental drug has received approval from the US Food and Drug Administration FDA to initiate a clinical trial focused on patients with ANCA Associated Vasculitis AAV is a rare autoimmune disorder that leads to chronic inflammation in small

18

Jun 2024

ReviR Therapeutics and Asieris Pharmaceuticals Reach Milestone in RNA-Targeted Cancer Therapy Development

ReviR Therapeutics a biotechnology firm focused on creating small molecule RNA splicing modulators for neurogenetic diseases and cancer and Asieris Pharmaceuticals a global leader in developing

17

Jun 2024

17

Jun 2024

MGI Tech and SeqOne Collaborate to Advance Complete Genomic Analysis

MGI Tech Co Ltd and its affiliates have announced a collaboration with SeqOne a leader in AIdriven genomic decision support software This partnership is focused on creating and validating comprehensive genomic analysis solutions designed specifically for Human Genetics and

15

Jun 2024

New Kite Research Highlights Yescarta® Effectiveness in Earlier Treatment Stages for Large B-Cell Lymphoma

Kite a Gilead Company has shared new results from three studies on Yescarta for treating relapsedrefractory large Bcell lymphoma at the European Hematology Association

Solovpe

press releasesRead more...

18

Jun 2024

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics

Primrose Bio Inc a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines announced a significant equity investment

18

Jun 2024

Mozart Therapeutics Doses First Cohort of Participants in Phase 1a/b Clinical Trial of MTX-101, in Development for Treatment of Autoimmune Diseases

Mozart Therapeutics a clinical stage biopharmaceutical company focused on the development of CD Treg modulators in autoimmune diseases today announce the dosing of the first cohort of participants

18

Jun 2024

Zuellig Pharma launches innovative B2B e-commerce healthcare purchasing platform, eZRx+, to better serve pharmacies and clinics in Asia

Zuellig Pharma a leading healthcare solutions company in Asia has announced that it has launched eZRx an enhanced version of its premier selfservice BB eCommerce healthcare purchasing platform

17

Jun 2024

VaxCell-Bio secures KDDF funding to develop solid tumor dual-target CAR-T therapy

VaxCellBio a pharmaceutical firm developing anticancer therapy products in Korea said it signed an agreement with the Korea Drug Development Fund last Friday to receive funding for the RD

15

Jun 2024

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

LIXTE Biotechnology Holdings Inc a clinical stage pharmaceutical company today announced a collaboration with Roche and the Netherlands Cancer Institute

15

Jun 2024

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that it has submitted an amendment to its Emergency Use Authorization

18 - 19

Jun 2024

18 - 20

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

18 - 19

Jun 2024

19 - 20

Jun 2024

LogiPharma Asia 2024

Equarius Hotel, Singapore

19 - 21

Jun 2024

CPHI & PMEC 2024

Shanghai, China

20 - 22

Jun 2024

20 - 22

Jun 2024
magazine-slider-image
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI China || PMEC China 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 3

    The Emergence of Organ-on-chips for Diseases Studies and Drug Development

    Giuseppe Maruccio

    Full Professor, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Anna Grazia Monteduro

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec, and INFN-Lecce

    Silvia Rizzato

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Giusi Caragnano

    PhD Student, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

  • 4

    Artificial Intelligence

    Mansi Athalye

    Assistant Professor, Department of Pharmaceutics, L. M.College of Pharmacy

    Daryai Uma Ghanshyam

    L. M.College of Pharmacy

  • 5

    3-dimensional Bioprinting of Tissue and Organs From bench to bedside

    Ryan Varghese

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University

    Sahil Salvi

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University

    Dileep Kumar

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California. Electronic address: [email protected]

KNOWLEDGE BANK

  • Interviews

    Takeda Pharmaceutical Company Limited

    Chief Medical & Scientific Officer

    Scientific progress depends upon collaboration iPS cell technology is at the forefront of pharmaceutical innovation and Takeda strives to bring innovative treatments to patients Both Takeda and CiRA have the common goal of providing patients and healthcare professionals with innovative new treatments
  • Research Insights

    Thin Films As An Emerging Platform For Drug Delivery

    AbstractPharmaceutical scientists throughout the world are trying to explore thin films as a novel drug delivery tool Thin films have been identified as an alternative approach to conventional dosage forms The thin films are considered to be convenient to swallow selfadministrable and fast dissolving dosage form all of which makes it as a versatile platform

  • Case Studies

    Diagnostics - Stable Aqueous Horseradish Peroxidase

    ChallengeThe main use of Horseradish peroxidise HRP is in diagnostic applications to produce a detectable signal indicating presence of a molecular target Typically HRP is used in conjugates with antibodies the antibody to recognise the molecular target an

  • White Papers

    Destination India: Reconfiguring Gelatin Value Chain

    Bovine Gelatin Industry Overview The global gelatin production in was thousand tons which is expected to grow at a CAGR of till Globally of gelatin is bovine bone based The yield conversion factor from bovine bone chips to gelatin is Bovine bone chips are widely used to manufacture pharmaceutical gelatin since it is more preferred due to its encapsulation properties and higher bl

EDITORIAL SECTION